Stock Titan Trading tools for traders and investors.

-

01:16:39 AM

Last MRNA Stock Market News

MRNA - Moderna Inc

03/08/21 9:00 AM

Nasdaq, NYSE : MRNA, BAX

Baxter BioPharma Solutions and Moderna Announce Agreement for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.

Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that they have entered into an agreement for Baxter BioPharma

RHEA-AI

neutral

03/08/21 7:00 AM

Nasdaq : MRNA

Shannon Thyme Klinger Joins Moderna as Chief Legal Officer and Corporate Secretary

Moderna Inc., Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Shannon Thyme Klinger will join the Company as Chief Legal Officer, effective June 1, 2021. She will serve on Moderna's Executive Committee and as

RHEA-AI

neutral

03/06/21 12:23 PM

Nasdaq : MRNA

Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a supply agreement with the Government of The Philippines for 13 million doses of the COVID-19 Vaccine Moderna.Under the terms of this agreement, deliveries would begin

RHEA-AI

neutral

03/05/21 1:30 AM

Nasdaq : MRNA

Moderna Announces New Drug Application Submitted to Import and Distribute Moderna's COVID-19 Vaccine Candidate in Japan

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Takeda Pharmaceutical Co., Ltd (NYSE: TAK) submitted a New Drug Application to the Government of Japan's Ministry of Health, Labour and Welfare (MHLW) to import and

RHEA-AI

neutral

03/04/21 11:15 AM

NYSE, Nasdaq : IBM, MRNA

Moderna and IBM Plan to Collaborate on COVID-19 Vaccine Supply Chain and Distribution Data Sharing

Today, Moderna (Nasdaq: MRNA) and IBM (NYSE: IBM) announced their intentions to explore technologies, including artificial intelligence, blockchain and hybrid cloud, that could help support smarter COVID-19 vaccine management. Central

RHEA-AI

positive

02/25/21 7:00 AM

Nasdaq : MRNA

Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the fourth quarter and fiscal year 2020 and highlighted pipeline progress."2020 was a historic year for Moderna. The

RHEA-AI

neutral

02/24/21 4:30 PM

Nasdaq : MRNA

Moderna Announces Additional Capital Investments to Increase Global Manufacturing Capacity for COVID-19 Vaccine

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announces it is making new capital investments to increase capacity at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity to

RHEA-AI

very positive

02/24/21 4:17 PM

Nasdaq : MRNA

Moderna Announces it has Shipped Variant-Specific Vaccine Candidate, mRNA-1273.351, to NIH for Clinical Study

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announces that it has completed manufacturing of clinical trial material for its variant-specific vaccine candidate, mRNA-1273.351, against the SARS-CoV-2 variant known as B.1.351 first

RHEA-AI

negative

02/18/21 8:00 AM

Nasdaq : MRNA

Moderna to Present at Upcoming Investor Conferences in February and March 2021

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in the following upcoming virtual investor conferences:SVB Leerink 10 th Annual Global Healthcare Conference on Thursday, February 25, 2021 at 1:00

RHEA-AI

neutral

02/16/21 9:00 AM

Nasdaq : MRNA

Moderna Provides U.S. COVID-19 Vaccine Supply Update

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided a supply update for the Moderna COVID-19 Vaccine in the United States, reporting that 45.4 million doses have been supplied to the U.S. Government to date. The Company

RHEA-AI

neutral

1 2 3 4 5 6 7 8 Next